Focus: Infection Control

Study says UV light cuts C. diff by 25 percent

Treating empty patient rooms can reduce infection rate in high-risk patients


Treating empty patient rooms with ultraviolet C light disinfection can reduce the rate of Clostridium difficile in high-risk patients who will later occupy the rooms, according to an article on the Becker's Infection Control & Clinical Quality website.

A new study published in Infection Control & Hospital Epidemiology conducted the disinfection technique and monitored its impact on C. diff infection rates.

The study examined a one-year period across three hematology-oncology units at the Hospital of the University of Pennsylvania in Philadelphia.

The study found UV light cuts C. diff by 25 percent. Rates increased by 16 percent in units outside of the study.

Read the article.

 



October 20, 2016


Topic Area: Infection Control


Recent Posts

Texas Law Limits Backup Power Mandates for Senior Care Facilities

As Texas relaxes generator mandates, healthcare facility managers now face tough decisions about emergency power investments and resident safety.


Cyber Crossfire: Why Healthcare Is Becoming a Battleground in Global Conflicts

As geopolitical tensions escalate, hospitals and critical suppliers are increasingly targeted in cyberattacks.


UPMC Presbyterian Receives $65 Million Gift for New Bed Tower

The tower is projected to open for patient care in early 2027.


Premier Health Partners Falls Victim to Cyber Incident

The incident occurred in July 2023.


Backup Power's Expanding Role in Emergency Preparedness for Healthcare

Manufacturers discuss design strategies, code shifts and lessons learned from real-world disasters.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.